Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...

A school year’s worth of short, accessible image-driven posts that invite a variety of kinds of writing. 2d ago By The Learning Network ...